µÚËľüÒ½´óѧһ¾Å¾Å¶þÄê¹¥¶Á²©Ê¿Ñ§Î»Ñо¿ÉúÈëѧÊÔÌâ ѧ¿Æ×¨Òµ£º *Tc lcu
=D;n#n 7
´«È¾²¡Ñ§ ¿¼ÊÔ¿ÆÄ¿: ÃâÒßѧ =
sZ58xA
!
=Scpo_
Ò». Ãû´Ê½âÊÍ(ÿÌâ4·Ö,¹²32·Ö) Z<D8{&AjS
9Xl[AVs:M
1. ICAM-1 jRiXN%
Yo%ph%e
2. interleukin 12(IL-12) qofD@\-
MHj
RPh
3. tumor infiltrating lymphocyte :'`y}'
G+7#!y Y
4. TCR/CD3 complex HTz5LAe~b7
H^ 'As;R
5. hematopoietin receptor family )
_n=it$
~Uw;6VXV1
6. individual idiotype(IdI) 7+9o<j@@o
'VgEf:BS
7. integrin ,I6li7V
7F2 WmMS
8. colony-stimulatory factor (CSF) ~+ kfb^<-
"7q!u,u
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© ui
RO,B}z
ZJe^MnE (G
1. ÃâÒßÇòµ°°×ÖØÁ´µÄ»ùÒòÈçºÎ½øÐÐÀà±ðת»»(class switching )? {8I,uQO
@r&*Qsf|
2. ¼òÊöɱÉËÐÔTϸ°û(Tc)ɱÉ˲¡¶¾¸ÐȾ°Ðϸ°ûµÄ»úÀí¡£ j"hNkCF
|yl,7m/B-G
3. ÉúÎïÓ¦´ðµ÷½Ú¼Á( biological response modifier,BRM)Ö÷ÒªÓÐÄļ¸Àà?¼òÒª½éÉÜÔÚ´«È¾ÐÔ¼²²¡·ÀÖÎÖеÄ×÷ÓᣠAl1_\vx7
e@Mg9VwDc
4. ¼òÊö¿¹ÔÌá³Êϸ°û(APC)Ó븨ÖúÐÔTϸ°û(Th)Ï໥×÷ÓõĹØÏµ¡£ cO$xT;kK
oN2#Jh%dH
Èý. ÎÊ´ðÌâ(ÿÌâ18·Ö,¹²36·Ö) J}NMF#w/;
>?O?U=:<
1. ÊÔÊö¸ÉÈÅËØµÄ·ÖÀ༰ÆäÉúÎïѧ×÷ÓÃÌØµã¡£Ö÷Òª¿ÉÒÔÖÎÁÆÄÄЩ´«È¾ÐÔ¼²²¡?¼òÊö¸ÉÈÅËØ¼ì²âµÄ·½·¨ºÍÔÀí¡£
STl8h}C
L{&>,ww
2. ºÎΪ»ùÒò¹¤³Ì¿¹Ìå?Ŀǰ¹úÄÚÍâÔÚ»ùÒò¹¤³Ì¿¹ÌåÑо¿ÖÐÓÐÄÄЩÖ÷Òª½øÕ¹? µÚËľüÒ½´óѧһ¾Å¾ÅÈýÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ѧ¿Æ×¨Òµ: ´«È¾²¡Ñ§¡¢ Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿: ÃâÒßѧ Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© 1. CD4 2. T cell receptor(TCR) ~x7CI
Mw3$QRM
3. immunoglobulin superfamily (IgSF) k%3)J"|/
Pbd[gKX_
4. selectin r+8)<Xt+p
#+QJ5VI:
5. anti-idiotypic antibody (¦ÁId) jzJQ/ZFS
b@c(Nv
6. major histocompatibility complex(MHC) E[WU
JH| D
7. immunotolerance i=L 86Ks
X::@2{-@y
8. biological reponse modifier(BRM) ?N<,;~
^vxx]Hji
9. immune reponse gene (Ir gene)
F!3p )?
ber&!9
10. reshaped antibody (or reconstituted antibody) X~UL$S;
X1d{7H8A2
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© w[F})u]E
O}%ES AB
1. ¼òÊö°×ϸ°û½éËØ6(IL-6)Ö÷ÒªµÄÉúÎïѧ»îÐÔ¡£ +.&P$`;TZj
l9C `:g
2. ϸ°û¶¾ÐÔTÁܰÍϸ°û(Tc»òCTL)Ó뿹ÌåÒÀÀµµÄϸ°û½éµ¼µÄϸ°û¶¾(ADCC)ɱÉË»úÀíÓкβ»Í¬? CuK>1_Dq
Zr1"'+-
3. ¼òÊöµÚ¢ôÐÍ(³Ù·¢ÐÍ)±ä̬·´Ó¦µÄ·¢Éú»úÀí¡£ g4=C]\1
Ux1j +}y
4. NKϸ°ûÓÐÄÄЩÖ÷ÒªµÄ±íÃæ±ê¼Ç?NKϸ°ûÓÐÄÄЩÖ÷ÒªµÄÉúÎïѧ»îÐÔ? qSlo)aP
+_ /ys!
Èý. ÎÊ´ðÌâ(ÿÌâ14·Ö,¹²28·Ö) ¹©´«È¾²¡Ñ§×¨ÒµÊÔÌ⣺ KB^8Z@(+
m_Pk$Vwx
1. »úÌåÓÐÄÄЩÃâÒßϸ°ûºÍÃâÒß·Ö×Ó²ÎÓ뿹²¡¶¾¸ÐȾ?ËüÃÇÊÇÈçºÎ·¢»Ó²¡¶¾ÃâÒß×÷ÓõÄ? 1TX3/]:
[<5/s$,i
2. Ŀǰµ¥¿Ë¡¿¹ÌåÔÚ²¡¶¾Ñ§ÖÐÓÐÄÄЩÖ÷ÒªÓÃ;?½ñºó¿ÉÄÜÓÐÄÄЩÖ÷ÒªµÄ·¢Õ¹·½Ïò? ¡¡ p7
!y#
[Rub
¹©Ïû»¯ÄÚ¿Æ×¨ÒµÊÔÌ⣺ +L"F] _?
+'SL5d*
1. ĿǰÌåÄÚºÍÌåÍâ¼ì²âÖ×Áö»¼ÕßÃâÒß¹¦Äܵķ½·¨Ö÷ÒªÓÐÄÄЩ?·Ö±ðÐðÊöÿÖÖ·½·¨µÄÔÀíºÍ½á¹û²â¶¨? NC!B-3?x
0C.5Qx
2. Ŀǰµ¥¿Ë¡¿¹ÌåÔÚÖ×ÁöѧÖÐÓÐÄÄЩÖ÷ÒªµÄÓÃ;?½ñºó¿ÉÄÜÓÐÄÄЩÖ÷ÒªµÄ·¢Õ¹·½Ïò? ¡¡ RhKDQGdd
2q]ZI
µÚËľüÒ½´óѧһ¾Å¾ÅËÄÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ѧ¿Æ×¨Òµ: [T4{K&
Xp|4 WM
´«È¾²¡Ñ§¡¢ Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿: 7FkiT
50|nQ:u,
̉񧄤 |=v,^uo
n:B){'S
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© g33Y$Xdk
I
L7kpH+y
1. CD8 Xs|d#WbX
9{U@s
2. T cell receptor ¦Á and ¦Â chain (TCR¦Á¦Â ) rXzq:
>r
C*.
3. immunoglobulin fold(Ig fold) 88<d<)7t
{>vgtk J
4. cadherin (Ca-dependent cell adhesion moleculers) F'>yBDm*OM
RhmkpboucC
5. idiotype-anti-idiotypic antibody immune network theory o3\^9-jmp
y{<js!au
6. HLA class II antigen nC
!NZ
!-n*]C
7. complementarity-determining region (CDR) W`u @{Vb]
<&`Rf6
8. perforin(or pore-forming protein ,PFP) ~N}Zr$D
cZ
!$XXA`
9. high affinity IL-2 receptor 'Lu xF1>
=`>e
i
10. artificial active immunization jj;TS%
"x.iD,>k
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© Het
>G{
<\uDtbK
1. ¼òÊö°×ϸ°û½éËØ2(IL-2)Ö÷ÒªµÄÉúÎïѧ»îÐÔ¼°ÆäÔÚÁÙ´²ÖÎÁÆÖеÄÓ¦Óᣠ_*g
.U=u
9bRUN<
2. Çë±È½ÏµÚ¢ñÐÍ(ËÙ·¢ÐÍ)³¬Ãô·´Ó¦ÓëµÚ¢ôÐÍ(³Ù·¢ÐÍ)³¬Ãô·´Ó¦µÄ·¢²¡Ìص㡣 6{udNv X
IO7gq+
3. ÊÔÊö·ÖÃÚÐÍIgA(secretory IgA)µÄ½á¹¹ÌصãºÍºÏ³É·ÖÃÚ¹ý³Ì¡£ S76MY&Vx23
g,o46`6"
4. ÊԱȽÏT¡¢BÁܰÍϸ°ûϸ°ûĤ±íÃæ·Ö×Ó(Èç±íÃæ¿¹Ô¡¢±íÃæÊÜÌåµÈ)µÄÒìͬµã¡£ N}[!QE
=
=Q*|L-g
Èý. ÎÊ´ðÌâ(ÿÌâ14·Ö,¹²28·Ö¡£Çë×¢Ò⣺ÿλ¿¼ÉúÖ»ÄÜ´Ó1¡¢2ÌâÖÐѡһÌâ,3¡¢4ÌâÖÐѡһÌâ,¹²´ðÁ½Ìâ,¶à´ðÕß²»¼Æ·Ö¡£) 1. Ŀǰ¼ì²âϸ°ûÒò×ÓÖ÷ÒªÓÐÉúÎïѧ»îÐÔ¼ì²â·¨ºÍÃâÒßѧ¼ì²â·¨,Çë¾ÙÀý·Ö±ðÐðÊöÁ½ÖÖ·½·¨µÄʵÑéÔÀí¡£ Z
eY*5m
?G7*^y&Q
2. ΪÁ˱ÜÃâIgG¿¹ÌåFc¶Î·ÇÌØÒìÐÔ×÷ÓÃ,³£Ó¦ÓÃθµ°°×øˮ½âµÄF(ab¡¯)2¶Î,ÊÔÎÊÈçºÎÓ¦ÓÃSDS-PAGE·½·¨¶ÔF(ab¡¯)2½øÐмø¶¨? eHGx00:
">h$(WCK
3. ÊÔÊö¿¹Ö×Áö»ùÒò¹¤³Ì¿¹ÌåµÄÑо¿½øÕ¹¡£ `'P&={p8
U6wy^!_X9
4. ÊÔÊö¿¹²¡¶¾»ùÒò¹¤³Ì¿¹ÌåµÄÑо¿½øÕ¹¡£ ¡¡ H/ Ql
B<Cg_C
µÚËľüÒ½´óѧһ¾Å¾ÅÎåÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ [euR<i*I#
I`jG
ѧ¿Æ×¨Òµ£ºÃâÒßѧ¡¢´«È¾²¡Ñ§¡¢Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿£ºÃâÒßѧ %qE"A6j
VK,{Mu=.9
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© 9M 1DE
Wlq3r#
1. immunoglobulin gene rearrangement _\,lv
\u
<tsexsw
2. the common chain of cytokine receptor (or a cytokine receptor subunit shared by some cytokine receptors) Z 5P4 H
{(asy}a9K
3. flow cytometry(FCM) i eWXr4@:
BG.8 q4[
4. carrier effect 2ve<1+V_
#)48dW!n
5. positive selection of T lymphocytes in thymus L*|P'
=(P$P
6. mouse TH1(Th1) and TH2(Th2) subsets &
@_PY
xI#rnx*
7. perforin (pore-forming protein ,PFP) (JjxrZ+L
QuI!`/N)z
8. ADCC(antibody-dependent cell-mediated cytotoxicity) ^'Rs`e
7i02M~*uS
9. SH-2(src-homology region 2) '"LaaTTs
d1t_o2
10. Ab2¦Â (internal image) Lc]hwMGR*
N:#$S$
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© (G$Q\>
iYw1{U
1. ½üÄêÀ´ÔÚÈËÀà°×ϸ°û·Ö»¯¿¹Ô(CD)Ñо¿ÁìÓòÖÐÓÐÄÄЩÖ÷Òª½øÕ¹? QR~4Fe
,VUOsNN4\
2. ²ÎÓë»î»¯Tϸ°ûÓë»î»¯Bϸ°ûÏ໥×÷ÓõķÖ×ÓÖ÷ÒªÓÐÄÄЩ?¼òÊöÆä½á¹¹ºÍ¹¦ÄÜ? YD9vWk\/
=JPY{'V O
3. ÊÔÊöHLAÔÚÁÙ´²ÉϵÄÖ÷ÒªÓ¦Óᣠ{9j0k`A
yzL9Ic
4. Àý¾ÙÈýÖÖ´ÓÈËÍâÖÜѪµ¥¸öºËϸ°û(PBMC)Öд¿»¯Tϸ°ûµÄ·½·¨,·Ö±ðÐðÊöÆäʵÑéÔÀíºÍÖ÷Òª²Ù×÷²½Öè¡£ v6! `H
I4UsDs*BD
5. ÆÀ¼Ûºìϸ°ûÉú³ÉËØ(EPO)¡¢¸ÉÈÅËØ(IFN)ºÍ¼¯Âä´Ì¼¤Òò×Ó(CSF)ÔÚÁÙ´²Ä³Ð©¼²²¡µÄÓ¦Óᣠg1 y@z8Z{
4 R8Qn^
Èý. Ñ¡ÔñÎÊ´ðÌâ(ÿÌâ10·Ö,¹²20·Ö¡£Çë°´±¨¿¼×¨Òµ´ðÌâ,Èç´ð·Ç±¾×¨ÒµÌâ»ò¶à´ðÌâ¾ùÊÓΪÎÞЧ¡£) H+gB|
\)aFYDq#\
ÃâÒßѧרҵ£º jJ2{g> P0P
OH]45bd
&7
1. ÊÔÊöϸ°ûÒò×ÓÊÜÌåÖÐ,Ig³¬¼Ò×å¡¢ÔìѪÒò×ÓÊÜÌ峬¼Ò×å¡¢Éñ¾Éú³¤Òò×ÓÊÜÌ峬¼Ò×åÒÔ¼°Ç÷»¯Òò×ÓÊÜÌ峬¼Ò×åµÄÖ÷Òª½á¹¹Ìصã,ÿ¸ö³¬¼Ò×åÀý¾Ù³ö2¸ö³ÉÔ±¡£ ZdPqU\G^q
f8f3[O!x
2. ÊԱȽÏÈËT¡¢BÁܰÍϸ°ûϸ°ûĤ±íÃæ·Ö×Ó(±íÃæ±ê¼Ç)µÄÒìͬµã,ËüÃÇ·Ö±ð²ÎÓëÄÄЩÖ÷ÒªµÄÃâÒß¹¦ÄÜ? 1E4`&?
S?D]P'<
´«È¾²¡Ñ§×¨Òµ£º V;)+v#4{
XMxm2-%olP
1. ÈËÀàÃâÒßȱÏݲ¡¶¾(HIV)¸ÐȾÈËÌåºó,ÃâÒß¹¦Äܿɷ¢ÉúÄÄЩÖ÷ÒªµÄ±ä»¯?»úÀíÊÇʲô?ÈçºÎ½øÐÐÏàÓ¦µÄÃâÒßѧ¹¦Äܼì²â£¿ 3Y +;8ld
YT)1_>*\
2. ÇëÆÀÊöÉö×ÛºÏÕ÷³öѪÈȲ¡¶¾(HFRSV)¸ÐȾºó»úÌåÃâÒßѧ±ä»¯µÄÓ벡ÀíËðÉ˵ĹØÏµ¡£ b%C7 kL-
J5Q.v;
Ïû»¯×¨Òµ£º .;,,{;
KMl3`+i
1.ÊÔÊöÓëÏû»¯ÏµÍ³ÓйصÄÖ×ÁöÏà¹Ø¿¹ÔÑо¿µÄ½øÕ¹¡£ &=T>($3r94
=t~]@?]1D
2.¼òÊöճĤÏà¹ØÁܰÍÑù×éÖ¯(mucosal assiociated lymphoid tissue,MALT)µÄ×é³ÉºÍ¹¦ÄÜÌØµã¡£·ÖÃÚÐÍIgAÊÇÈçºÎ½øÐкϳɺͷÖÃÚµÄ? 5RY-.c4}
pMAFZfte!x
µÚËľüÒ½´óѧһ¾Å¾ÅÁùÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ÃâÒßѧÊÔÌâ @.G;dL.f{
3fYfj
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© #0^a-47PA<
$0~1;@`rQ6
1. Fas(CD95)/FasL ir|L@Jj,
oIE3`\xS
2. common chain of cytokine receptor b`;&o^7gMO
e%9zY{ABR%
3 . TCR/CD3 complex y^
st
T^
e%7#e%1s
4. negaive selection of thymocytes 3?!c<^"e
$o)}@TC
5. artificial active immune usi3z9P>n
Wk
}}f|O0
6. anti-idiotypic ^7*zi_Q
{817Svp@
7. IgSF [l~G7u.d
_ZK*p+u%
8. Integrin .GCJA`0h
|h.@Xy
9. chemokine \@{TF((Y
YlZ&4
10. B7/CD28 xd4~[n\hm
+Je%8jH
¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²60·Ö£© .W\x{h
yy`XtJBWWs
1. ±È½ÏMHC¢ñºÍMHC¢òÀ࿹ԲÎÓëµÄ¼Ó¹¤Ìá³Ê¿¹ÔµÄ¹ý³Ì¡£ m:9|5W
/%bnG(4
2. ±È½ÏCTLºÍNKɱÉ˰Ðϸ°ûʱʶ±ðºÍɱÉË»úÖÆµÄÌØµã¡£ "=2'O qp1
zXIdup@
3. ±È½ÏÃâÒßѧ¼ì²â·¨ºÍÉúÎïѧ»îÐÔ¼ì²â·¨¼ì²âϸ°ûÒò×ÓµÄÓÅȱµã¡£ YQR[0Y&e=
bUuQ"!>ppu
4. ·¢ÏÖÒ»ÖÖеİ×ϸ°û·Ö»¯¿¹Ô»òÖ×ÁöÏà¹Ø¿¹Ô,²¢ÖƱ¸Á˵¥¿Ë¡¿¹Ìå,ÊÔÉè¼ÆÊµÑé·½°¸¿Ë¡´Ë»ùÒò¡£ |[
)pQGw
M'pIAm1p
5. Ñ¡ÔñÏÂÊöÖÐÒ»¸öרÌâ,ÐðÊöÎÒ¹úÔÚÕâÒ»Ñо¿ÁìÓòµÄÏÖ×´¼°ÃæÁÙµÄÌôÕ½1)Ö×ÁöÃâÒߣ»(2)»ùÒòÖÎÁÆ£»(3)CD¿¹Ô¡£ Y3H5}4QD
sH%Ts@Pl
µÚËľüÒ½´óѧһ¾Å¾ÅÆßÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÃâÒßѧÊÔÌâ }V 4u`=
zNg[%{mz
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© l.BiE<&
/^WOrMR
1. B7/CD28 w8`B}Dr23
UMK9[Iy$<M
2. Th1 subset )OK"H^}f
_SMi`ie#
3. seven predicated transmembrane domain receptor superfamily£¨STR superfamily£© fk\]wFj
WwxV}?Cf+
4. antibody affinity maturation ^E".`~R
@h/-P'Lc=7
5. AP-1 dt/-0~U
(#]9{C;
6. single chain variable fragment£¨ScFv£© h\+8eeIl
;s+3#Py
7. NK cell receptor e2L>"/
_`,ZI{.J^
8. Zinkernagel-Doherty phenomenon 4E+8kz'
gu&W:FY
9. Ig fold Qv
J29
?A-f_0<0
10. CD40/CD40L **.23<n^W
E%a&6W
¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²36·Ö£© }'
Ph^
%ox
cg9*+]rc
1. ÊÔÊöÐØÏÙ΢»·¾³¶ÔÐØÏÙϸ°ûµÄÑ¡Ôñ×÷Óü°ÆäÓëTϸ°û¹¦ÄÜÐÔÑÇȺÐγɵĹØÏµ¡£ ^oNcZK>
t3=K>Y@w
2. ÊÔÊöÌåÒºÃâÒßÓ¦´ðµÄ¹æÂÉ£¬»ØÒä·´Ó¦ºÍ¿¹ÌåÀà±ðת»»µÄ»úÖÆÊÇʲô£¿ !/X>k{
n(CM)(ozU
3. ÊԴӽṹºÍ¹¦ÄܵȽǶȣ¬²ûÊö°×ϸ°û·Ö»¯¿¹Ô£¨CD£©¡¢Õ³¸½·Ö×Ó£¨integrin£©ºÍÃâÒßÇòµ°°×³¬¼Ò×壨IgSF£©ÈýÀà·Ö×ÓµÄÏ໥¹ØÏµ¡£Ä¿Ç°ÔÚÕâÒ»ÁìÓòÖÐÖ÷ÒªÑо¿ÈȵãÊÇʲô£¿ FtlJ3fB@
D}UgC\u
Èý. ÎÊ´ðÌ⣨24·Ö£¬µÚ1ÌâΪÃâÒßѧרҵ¿¼ÉúÊÔÌ⣬µÚ2ÌâΪѪҺ²¡Ñ§¿Æ¿¼ÉúÊÔÌ⣬µÚ3ÌâΪÏû»¯ÄÚ¿Æ¿¼ÉúÊÔÌ⣬ֻÔÊÐí´ð±¾×¨ÒµÊÔÌ⣩ ;vn0b"Fi3
XEN-V-Z%*
1. ÊԱȽÏTCRºÍBCR½á¹¹¼°Æäʶ±ð¿¹Ô¡¢ÁܰÍϸ°û»î»¯ÐźŵķÖ×Ó»úÀí¡££¨ÃâÒßѧרҵ£©¡£ MM( ,D&
Z
(!Xb8rV0_
2. ÊÔÊö°×Ѫ²¡ÃâÒßѧ·ÖÐÍÀíÂۺͷ½·¨µÄÑо¿½øÕ¹¡££¨ÑªÒº²¡Ñ§×¨Òµ£©¡£ ezri9\Ju
0wAB;|~*62
3. ÊÔÊöÖ×ÁöÒßÃçµÄÑо¿½øÕ¹¡££¨Ïû»¯ÄÚ¿Æ×¨Òµ£©¡£ 9fOE
.
5r dt
Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ £¨ÃâÒßѧרҵºÍרҵ»ù´¡£© Ds{bYK_y
2X(2O':Uc
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© 7e D`
is
D&]xKx
1.Co-stimulators (or co-stimulating molecules) qL
w^Qxo
,'sDauFn
2.NK-kB x@:98P
`m$,8f%j6_
3.Immunoglobulin superfamily S&;)F|-q
:_+U[k(#
4.antigen-presenting cell (APC) -w'g0/fD
>)mF'w
5.death domain `V.tqZF
T8x /&g''
6.CCR and CXCR 9<"F3
F0|
c)q=il7ef
7.Lectin (or mitogen) vq@"y%C4
@(."[O:
8.Clusters of differentiation, CD) !A14\
[~;wCW,1
9.B7 family w[G-=>;
`];ne]xM
10.Cytotoxic T lymphocyte, CTL) 7dlMDHp\Y
=CL,+
11.IL-15 and IL-15 receptor (IL-15R) jT;'T$
':utU1dL
12.MHC restriction QqXaXx;
e`5:46k|
13.Affinity-chromatography K5(T7S
[u-=<hnoa
14.Cyctosprin A, CsA `2xt%kC
Aiqb*v$
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) *6v5JH&K
{4%ddJn[.)
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© 9 I&[6}
-{yG+1
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 #O'g*]j
Zh?n;n}
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ y! j>_m){w
V0gu0+u~R
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£ rj<-sfs
-BsZw.
7P
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© ZjnWbnW
ork{a.1-_w
ÃâÒßѧרҵ£º t"6u
HZ\=
NDz
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ \/r]Ra
F<
,"{L
Ïû»¯ÄÚ¿Æ£º 2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ .GW)"`HbU
@$wfE\_L
ѪҺ²¡Ñ§×¨Òµ£º 3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿ Fk?KR
ck8Qs08
Ò»¾Å¾ÅÄê¾Å²©Ê¿ÉúÈëѧ¿¼ÊÔÊÔÌâ (רҵ»ù´¡: ÃâÒßѧ) zG&yu0;D6
a$
Ghb]
Ò».Ãû´Ê½âÊÍ(ÿÌâ5·Ö,¹²45·Ö) ZXWm?9uw
I>>X-}
1. ADCC(antibody dependent cell-mediated cytotoxicity) e#?rK=C?9
C7Hgzc|U
2. »·æß¾úËØ(cyclosporin) 1qwJPM
ab<7jfFIa
3. KIR(killer cell inhibitory receptor) (HeIO
CWnRRZ}r
4. HLDA(human leucocyte differentiation antigen) r / L
U[!wu]HMF
5. Interleukin 18(IL-18) g^:7mG6C
t%Y}JKLR
6. ÕûºÏËØ(integrin) QST-!`]v
iP?=5j=4
7. Fas/FasL $H7T|`WI.,
1.j;Xo/+:V
8. FcR(ÃâÒßÇòµ°°×Fc¶ÎÊÜÌå) $yMNdBI[
NW?h~2
9. ϸ°û¼äÕ³¸½·Ö×Ó(ICAM) cX48?srG
Il<ezD{
10. Th1/Th2 l' a<k"
HQ3kxOT
11. »ùÒòÒßÃç(DNAÒßÃç) $C6O<A
`"j _]
12. chemokines and chemokine receptor i>@"&
xXZ{
13. ÃâÒßÄÍÊÜ 7vK}aOs0
JA^Y:@
<{/
14. ¹²´Ì¼¤·Ö×Ó `T$CUlt6
hjY)W;
15. ËÀÍö½á¹¹Óò(death domain) A(qy>x-BI
~ny4Ay$#
¶þ.ÎÊ´ðÌâ(µÚ1¡¢2Ìâ¸÷18·Ö,µÚ3Ìâ19·Ö) P 4jg]g
'B$qq[l]S
1. ÊԱȽÏɱÉËÐÔTϸ°û(CTL)Óë×ÔȻɱÉËϸ°û(NK)ÔÚɱÉ˰Ðϸ°û¹ý³ÌÖÐ,ʶ±ðϸ°û¶¾¼°½éµ¼ÃâÒß¹¦ÄÜÓкβ»Í¬? 8{
J{)gF
Ptv=Bwg
2. 70Äê´úÒÔÀ´,ÓйØIgºÍÌåÒºÃâÒßÑо¿´æÔÚÒÔϼ¸ÏîÖØ´ó·¢ÏÖºÍÍ»ÆÆ¶ø»ñµÃҽѧºÍÉúÎïѧŵ±´¶û½±,Çë·Ö±ð²ûÊöËüÃǵÄÀíÂÛÒâÒå¼°ÔÚҽѧʵ¼ùÖеÄÓ¦Óᣠ+"2IQme5
twJ)h :!_y
£¨1£©1972Ä꣺θµ°°×øºÍľ¹Ïµ°°×øˮ½âIg£¬»ñµÃFab¡¢Fc¡¢F£¨ab¡¯£©2µÈƬ¶Î qUF}rlS=r
j`kw2
(
£¨2£©1977Ä꣺·ÅÉäÃâÒß·¨ D<*#. >
S,TK;g
£¨3£©1984Ä꣺ÁܰÍϸ°ûÔÓ½»ÁöºÍµ¥¿Ë¡¿¹Ìå uWKc
.
RzLbPSTQ
£¨4£©1987Äê: Ig»ùÒòµÄ½á¹¹ 3. ½üÄêÀ´ÔÚÖ×ÁöÃâÒßÑо¿ÁìÓòÖÐÓÐÄÄÐ©ÖØÒª½øÕ¹?ÊÔÊöµ±Ç°Ìá¸ß»úÌ忹Ö×ÁöÃâÒßµÄÖ÷Òª²ßÂÔ¡£ 2kU=9W6ND
,V2,FoJ 9
Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(ÃâÒßѧרҵ) ÎÊ´ðÌâ(ÿÌâ25·Ö) 5//.q;z
X(Zo
uyD<
1. ÊԱȽÏTϸ°ûÊÜÌ壨TCR£©¡¢Bϸ°ûÊÜÌ壨BCR£©ºÍNKϸ°ûÊÜÌ壨NKCR£©µÄ×é³É£¬Ê¶±ðÅäÌåÒÔ¼°ÐźÅתµ¼µÄÒìͬµã¡£ _4jRUsvjY
bC@9
*/i
2. ÒÔÐØÏÙÒÀÀµ¿¹Ô´Ì¼¤»úÌå²úÉú¿¹ÌåµÄÃâÒßÓ¦´ðΪÀý£¬Tϸ°ûºÍBϸ°ûÊÇÈçºÎÏ໥×÷Óã¿ÓÐÄÄЩճ¸½·Ö×Ӻ͹²´Ì¼¤·Ö×Ó²ÎÓëT¡¢Bϸ°ûµÄÏ໥×÷Óã¿ ?1u2P$d
-h<
Rby
3. Éö×ÛºÏÕ÷³öѪÈÈ(HFRS)²¡¶¾µÄ½á¹¹»ùÒòÒѾ¸ãÇå³þ,ΪÁË֤ʵHFRS²¡¶¾¸ÐȾ»úÌå(ÒÔBalb/CСÊóΪÀý)¿É²úÉúHFRS²¡¶¾ºËÒ¿ǵ°°×(NP)ÌØÒìÐÔCTL,²¢ÔÚÃâÒß·À»¤ÖÐÆðÖØÒª×÷ÓÃ,ÇëÓ¦ÓÃÃâÒßѧÀíÂۺͷ½·¨,Éè¼ÆÒ»ÏµÍ³ÊµÑé,¼ÓÒÔ֤ʵ¡£ 4. Àý¾Ù¶þ¸ö½üÄêÀ´Ï¸°ûºÍ·Ö×ÓÃâÒßѧÑо¿ÖгöÏÖµÄеÄÈȵã,Çë·Ö±ðÆÀÊöÆäÑо¿ÒâÒå¡¢·¢Õ¹Ç÷ÊÆÒÔ¼°Ó¦ÓÃǰ¾°¡£